- Home
- FVRR vs PLRX Comparison
FVRR vs PLRX Comparison
Compare FVRR & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVRR
- PLRX
- Stock Information
- Founded
- FVRR 2010
- PLRX 2015
- Country
- FVRR Israel
- PLRX United States
- Employees
- FVRR N/A
- PLRX N/A
- Industry
- FVRR Business Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- FVRR Consumer Discretionary
- PLRX Health Care
- Exchange
- FVRR Nasdaq
- PLRX Nasdaq
- Market Cap
- FVRR 791.5M
- PLRX 641.5M
- IPO Year
- FVRR 2019
- PLRX 2020
- Fundamental
- Price
- FVRR $32.11
- PLRX $12.98
- Analyst Decision
- FVRR Buy
- PLRX Strong Buy
- Analyst Count
- FVRR 10
- PLRX 7
- Target Price
- FVRR $32.00
- PLRX $40.50
- AVG Volume (30 Days)
- FVRR 1.1M
- PLRX 500.0K
- Earning Date
- FVRR 10-30-2024
- PLRX 11-07-2024
- Dividend Yield
- FVRR N/A
- PLRX N/A
- EPS Growth
- FVRR N/A
- PLRX N/A
- EPS
- FVRR 0.25
- PLRX N/A
- Revenue
- FVRR $379,317,000.00
- PLRX N/A
- Revenue This Year
- FVRR $9.76
- PLRX N/A
- Revenue Next Year
- FVRR $8.27
- PLRX $585.71
- P/E Ratio
- FVRR $126.97
- PLRX N/A
- Revenue Growth
- FVRR 7.45
- PLRX N/A
- 52 Week Low
- FVRR $18.83
- PLRX $10.22
- 52 Week High
- FVRR $32.86
- PLRX $19.62
- Technical
- Relative Strength Index (RSI)
- FVRR 70.13
- PLRX 44.30
- Support Level
- FVRR $27.78
- PLRX $12.01
- Resistance Level
- FVRR $30.37
- PLRX $12.94
- Average True Range (ATR)
- FVRR 1.43
- PLRX 0.88
- MACD
- FVRR 0.19
- PLRX -0.23
- Stochastic Oscillator
- FVRR 85.98
- PLRX 28.11
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.